Ideal Patient Populations for RSV Vaccination
Panelists discuss that pharmacies should prioritize practical workflow and patient management over clinical preference when administering RSV vaccines, since all…
Key Differences Between FDA-Approved RSV Vaccines
Panelists discuss the 3 FDA-approved RSV vaccines for high-risk adults—2 recombinant protein-based (1 adjuvanted, 1 bivalent) and one mRNA-based—highlighting differences…
Targeting Patients at Risk for Severe RSV Disease
Panelists discuss how pharmacies can boost RSV vaccination rates in high-risk adults by leveraging patient visits—especially during other immunizations—using integrated…
Implied Vaccine Burden and Associated Misinformation
Panelists discuss how pharmacists can address patients’ growing vaccine fatigue and misconceptions—such as underestimating RSV’s severity in adults or believing…
Exploring High-Risk Populations for RSV Complications
Panelists discuss how pharmacists can identify high-risk adults for severe RSV—such as those with chronic conditions or advanced age—by reviewing…
Pathophysiology and Complications Associated With Respiratory Syncytial Virus (RSV)
Panelists discuss clinical strategies to improve RSV vaccine uptake in high-risk adults by reviewing disease severity, comparing approved vaccines, and…
US plans 35% tariffs on Canada imports
President Donald Trump said the duties will take effect Aug. 1 while decrying the country’s retaliatory levies to U.S. tariffs.
AI boom offsets EV slump as Disco raises quarterly forecast
Japanese semiconductor equipment maker Disco has revised its financial forecast for the second quarter of 2025, now expecting a consolidated…
Google DeepMind spinoff Biotech moves AI-designed drug to human trials
The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter…
Apple plans new MacBook Pro, iPhone 17e and iPads by early 2026
Apple Inc. is planning an ambitious pipeline of new products for release during the first half of 2026, including a…